Malaysia Over-the-Counter (OTC) Healthcare Market Size by Categories, Distribution Channel, Market Share and Forecast, 2021-2026

The publisher's Country Profile report on the OTC healthcare sector in Malaysia provides insights on high growth markets to target, trends in the usage of category level distribution data and companies market shares.

The Malaysian OTC healthcare sector was led by traditional medicines in value terms. However, the cough and cold preparations category is forecast to register fastest value growth during 2021-2026. Drug stores & pharmacies is the leading channel for distribution of OTC healthcare products in the country. GlaxoSmithKline, Johnson & Johnson Services Inc and Darya-Varia Laboratoria Tbk are the leading players in the Malaysian OTC healthcare.

What else is contained?

• Sector data: Overall sector value data with growth analysis for 2016-2026
• Category coverage: Value and growth analysis for Analgesics, ‘cough and cold preparations’, first aid kits, indigestion preparations, medicated skin products, ‘plasters & bandages’, topical OTC medicines, traditional medicines, ‘vitamins and minerals’ and ‘other OTC healthcare products’ with inputs on individual segment share within each category and the change in their market share forecast for 2021-2026
• Leading players: Market share of companies (in value terms) and private labels (in value terms) in 2021
• Distribution data: Percentage of sales within each category through distribution channels such as cash & carries and warehouse clubs , convenience stores, drug stores & pharmacies, food & drinks specialists, hypermarkets & supermarkets, and other general retailers

Scope

• The per capita expenditure of OTC healthcare in Malaysia was lower than the global level but higher than the regional levels in 2021
• The Malaysian OTC healthcare sector is expected to register growth at a CAGR of 44% in terms of value during 2021-2026
• Drug stores & pharmacies was the leading distribution channel in the Malaysian OTC healthcare sector, with a value share of 699% in 2021
• GlaxoSmithKline accounted for a value share of 15% in 2021

Reasons to Buy

• Identify high potential categories and explore further market opportunities based on detailed value and volume analysis
• Existing and new players can analyze key distribution channels to identify and evaluate trends and opportunities
• Gain an understanding of the total competitive landscape based on detailed company share analysis to plan effective market positioning
• Our team of analysts have placed a significant emphasis on changes expected in the market that will provide a clear picture of the opportunities that can be tapped over the next five years, resulting in revenue expansion
• The packaging analysis report helps manufacturers, in identifying the most commonly used packaging materials in the sector
• Analysis on key macro-economic indicators such as real GDP, nominal GDP, consumer price index, household consumption expenditure, population (by age group, gender, rural-urban split, and employed people and unemployment rate. It also includes economic summary of the country along with labor market and demographic trends